Prof. Ming-Yow Hung | Cardio-Oncology | Best Researcher Award Posted on 26/11/202426/11/2024 by Pencis Prof. Ming-Yow Hung | Cardio-Oncology | Best Researcher Award Taipei Medical University | Taiwan Author Profile Scopus ORCID ID Biography: Prof. Ming-Yow Hung, MD, PhD πππ©Ί Name: Prof. Ming-Yow Hung Citizenship: Taiwanese π Education: Medical Degree: School of Medicine, College of Medicine, Chang Gung University (1989β1995). PhD: Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine (2007β2017). π Military Service: Lieutenant General Physician, Navy, Taiwan, Republic of China (1996β1998). πΌ Professional Roles: Attending Cardiologist: Division of Cardiology, Shuang Ho Hospital, Taipei Medical University (2008βpresent). Professor of Medicine: Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University (since 2022). π Board Certifications: Internal Medicine (2001). Adult Cardiology (2004). π¬ Research Interests: Interventional Cardiology Echocardiography Basic Cardiovascular Science π Editorial Contributions: Editorial Board Member: Enliven: Clinical Cardiology and Research (2015βpresent). Journal of Epidemiological Research (2015βpresent). SM Vascular Medicine (2015βpresent). Guest Editor: Journal of Interventional Cardiology (2019β2020). Oxidative Medicine and Cellular Longevity (2023). Frontiers in Cardiovascular Medicine (2023). Life (2023). π― Research Projects: Investigating macrophage polarization in coronary artery spasm using CRISPR core facilities (2020β2021). Mechanisms of Garcinol as Ξ±-7nAChRs Inhibitor in cardiac damage (2021β2022). LPCAT4/GDE7 axis as therapeutic targets in coronary artery spasm (2022β2023). SCAP/SREBPs signaling in lipoprotein(a)-induced macrophage polarization (2023β2026). π Professional Affiliations: Fellow, American Heart Association (2013βpresent). Fellow, American College of Cardiology (2014βpresent). Member of multiple Taiwanese and international cardiology societies. π Honors and Awards: Clinical Medicine Research Award, Taipei Medical University (2014, 2015). Recognition for outstanding contributions to cardiovascular research and patient care. Prof. Hung is renowned for his dedication to advancing cardiovascular science, particularly in coronary artery spasm and interventional cardiology. πβ€οΈ π CONCLUSION Prof. Ming-Yow Hung is a distinguished cardiologist and academic leader, whose expertise in interventional cardiology, echocardiography, and cardiovascular science has earned him national and international recognition. As a Full Professor at Taipei Medical University and a Fellow of esteemed cardiology organizations, he has made significant contributions to both clinical practice and research. ππ¬NOTABLE PUBLICATION: Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory Ξ± 7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm Authors: Lin, Y.-K.; Yeh, C.-T.; Kuo, K.-T.; Hu, P.; Hung, M.-Y. Journal: Oxidative Medicine and Cellular Longevity Year: 2022 The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review Authors: Karimabad, M.N.; Kounis, N.G.; Hassanshahi, G.; Hung, M.-Y.; Nadimi, A.E. Journal: Vaccines Year: 2021 The Effect of Long COVID-19 Infection and Vaccination on Male Fertility: A Narrative Review Authors: Pourmasumi, S.; Nazari, A.; Ahmadi, Z.; Altay, S.; Kounis, N.G. Journal: Vaccines Year: 2022 βWhen,β βWhere,β and βHowβ of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review Authors: Kounis, N.G.; Gogos, C.; de Gregorio, C.; Velissaris, D.; Koniar, I. Journal: Balkan Medical Journal Year: 2024 Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review Authors: Hung, M.-J.; Yeh, C.-T.; Kounis, N.G.; Hu, P.; Hung, M.-Y. Journal: International Journal of Molecular Sciences Year: 2023
Prof Dr. Yinyuan Ding | Tumorigenesis | Best Researcher Award Posted on 21/10/202421/10/2024 by Pencis Prof Dr. Yinyuan Ding | Tumorigenesis | Best Researcher Award Chongqing Medical University | China Author Profile Scopus ORCID ID Professor Yinyuan Ding π Professor of Oncology π₯ Chongqing Medical University π Academic and Professional Background: Professor Yinyuan Ding obtained a Ph.D. from Peking University in 2011 and pursued postdoctoral training at UT Southwestern Medical Center, where he was later promoted to Assistant Professor in 2018. In 2019, he returned to China and joined Chongqing Medical University as a professor. His research explores tumorigenesis and glucolipid metabolic disorders, focusing on the LRP1 receptor’s role in liver and vascular signaling, with implications for novel treatments for Hepatocellular Carcinoma (HCC) and Metabolic Associated Steatohepatitis-Liver Disease (MASLD). π¬ Research and Innovations: Principal Investigator 2023-2026: “The role of LRP1 in hepatic glucose metabolism and HCC progression” (National Natural Science Foundation of China) 2021: “The role of Asprosin in hepatocellular carcinoma” (Chongqing Municipal Human Resources Bureau) Participant 2015-2020: “VLDL and ApoE receptors metabolism” (NIH-NHLBI) 2011-2015: “Cell signaling and cholesterol-lipoprotein receptors” (NIH) π Journals Published: Advanced Science, Elife, Science Signaling, EBioMedicine, JBC π€ Collaborations: Collaborates with Joachim Herz (UT Southwestern Medical Center, USA) π₯ Professional Memberships: Director of the China Branch, International Atherosclerosis Society 𧬠Areas of Research: Oncology Tumorigenesis Hepatology Lipoprotein & Lipid Research π Contributions: Professor Ding’s groundbreaking research on LRP1 has revealed its multifaceted roles in regulating cholesterol and glucose metabolism. His work identified a critical mechanism by which LRP1 affects hepatic insulin resistance, dyslipidemia, and HCC progression. This novel insight into LRP1’s function opens pathways for innovative therapeutic strategies for cancer and metabolic disorders. β¨Conclusion: In summary, Professor Yinyuan Ding is a distinguished expert in oncology and hepatology, with a strong focus on the molecular mechanisms of tumorigenesis and lipid metabolism disorders. His innovative research on LRP1 has led to significant breakthroughs in understanding liver disease and cancer progression, paving the way for novel therapeutic strategies. With a wealth of experience from top institutions and numerous prestigious publications and patents, Professor Ding continues to make impactful contributions to the field of cancer research, driving advancements in both basic science and clinical applications. π ππ¬NOTABLE PUBLICATION: 1. LRP1 facilitates hepatic glycogenesis by improving the insulin signaling pathway in HFD-fed mice Authors: Guo, X., Pu, J., Tang, Z., Liu, T., Ding, Y. Journal: Animal Models and Experimental Medicine Year: 2024 2. Erratum: Correction: LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis Authors: Xian, X., Ding, Y., Dieckmann, M., Tsai, S., Herz, J. Journal: eLife Year: 2017 (Erratum published in 2024) 3. Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1-Mediated Activation of NF-ΞΊB Signaling Authors: Guo, X., Yang, F., Liu, T., Herz, J., Ding, Y. Journal: Advanced Science Year: 2024